Sandoz releases Pulmicort Respules generic

July 28, 2015 by Chain Drug Review asthma medication, budesonide inhalation suspension, generic version of Pulmicort Respules, Novartis, Peter Goldschmidt, Sandoz Supplier News

PRINCETON, N.J. — Sandoz has launched budesonide inhalation suspension, an asthma medication, in the U.S. market. The Novartis subsidiary said Tuesday that it will market its budesonide inhalation suspension in 1-mg strength, and it expects 180-day generic drug marketing exclusivity for that dosage. The product is a a generic version of Pulmicort Respules inhalation suspension